Dr. Marc Siegel says a new experimental pill developed to treat COVID-19 could be the "holy grail of therapeutics" used against the virus. First-stage testing of Molnupiravir, developed by Merck and ...
Marshall Gunnell is a Tokyo-based tech journalist and editor with over a decade of experience covering IT, cybersecurity and data storage. Alongside CNET, his work has appeared in ZDNET, Business ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback